Xtant Medical 

$0.4081
20
-$0.01-2.81% Monday 20:00
+$0.00+0%Monday 20:00盤後

統計

當日最高
0.4101
當日最低
0.41
52週高點
0.95
52週低點
0.39
成交量
293
平均成交量
-
市值
57.24M
本益比
41.99
股息殖利率
-
股息
-

即將到來

財報

30Jul預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
下一步
-0.09
0.03
0.15
0.28
預期EPS
-0.02
實際EPS
不適用

財務

3.71%利潤率
有盈利
2020
2021
2022
2023
2024
2025
133.93M營收
4.97M淨利

分析師評級

1.00平均目標價
最高預估為 1.00。
來自過去6個月內的 1 則評分。這不是投資建議。
買入
100%
持有
0%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 XTNT 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming proteins to aid the healing process. OsteoSponge SC is specifically designed to repair bone defects in the subchondral area of joints. Other items are OsteoSelect DBM Putty, fostering osteoinductive bone regeneration, and OsteoSelect PLUS DBM Putty, which functions as a bone void filler and graft substitute for procedures involving the pelvis, extremities, and posterolateral spine. Additionally, the line features OsteoFactor, containing diverse proteins and peptides that facilitate bone formation and remodeling, along with OsteoWrap and OsteoVive Plus, a cellular bone matrix enriched with growth factors. 2. Allograft Technologies: Under the 3Demin brand, Xtant Medical provides a range of allografts (human bone grafts) engineered to maximize both osteoconductivity and osteoinductive capabilities. This includes specialized sports allografts used for repairing anterior and posterior cruciate ligaments, ACL reconstruction, and meniscal repairs. They also offer milled spinal allografts, where cortical bone is precisely shaped to specific dimensions, as well as traditional allografts applicable across numerous medical disciplines such such as orthopedics, neurology, podiatry, oral/maxillofacial surgery, genitourinary, and plastic/reconstructive surgery. 3. Spinal Fixation and Fusion Systems: The company furnishes a variety of sophisticated spinal devices. These include the Certex spinal fixation system, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, the Xpress minimally invasive pedicle screw system, and Fortex Pedicle screw systems. Further systems encompass Calix, for use in cervical and thoracolumbar regions, the Axle-X interspinous fusion system, Irix-C for cervical integrated fusion, and the Irix-A Lumbar integrated fusion system. The company underwent a name change in July 2015, transitioning from its former identity as Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.
Show more...
執行長
Mr. Sean E. Browne
員工
151
國家
美國
ISIN
US98420P3082

上市

0 Comments

分享你的想法

FAQ

Xtant Medical 今天的股價是多少?
XTNT 目前價格為 $0.41 USD,過去 24 小時下跌了 -2.81%。在圖表上更密切關注 Xtant Medical 股票的表現。
Xtant Medical 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 XASE 交易所,Xtant Medical 的股票以代號 XTNT 進行交易。
Xtant Medical 的股價在上漲嗎?
XTNT 股票較上週下跌 -2.72%,本月下跌 -8.29%,過去一年 Xtant Medical 下跌 -36.57%。
Xtant Medical 的市值是多少?
今天 Xtant Medical 的市值為 57.24M
Xtant Medical 下一次財報日期是什麼時候?
Xtant Medical 將於 July 30, 2026 公布下一次財報。
Xtant Medical 上一季度的財報如何?
XTNT 上一季度的財報為每股 -0.02 USD,預估為 -0.02 USD,帶來 -33.33% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Xtant Medical 去年的營收是多少?
Xtant Medical 去年的營收為 133.93MUSD。
Xtant Medical 去年的淨利是多少?
XTNT 去年的淨收益為 4.97MUSD。
Xtant Medical 有多少名員工?
截至 July 14, 2026,公司共有 151 名員工。
Xtant Medical 位於哪個產業?
Xtant Medical從事於Health & Wellness產業。
Xtant Medical 何時完成拆股?
Xtant Medical 上次拆股發生於 February 14, 2018,比例為 1:12。
Xtant Medical 的總部在哪裡?
Xtant Medical 的總部位於 美國 的 Belgrade。